Literature DB >> 17823149

Pharmacovigilance in developing countries.

Munir Pirmohamed, Kwame N Atuah, Alex N O Dodoo, Peter Winstanley.   

Abstract

Mesh：

Year:  2007        PMID： 17823149      PMCID： PMC1971195          DOI： 10.1136/bmj.39323.586123.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Ethnicity and adverse drug reactions.

Authors:  Erik Eliasson
Journal:  BMJ       Date:  2006-05-20

2.  Beyond registration--measuring the public-health potential of new treatments for malaria in Africa.

Authors:  Trudie Lang; Dyfrig Hughes; Tom Kanyok; Jane Kengeya-Kayondo; Vicki Marsh; Ane Haaland; Munir Pirmohamed; Peter Winstanley
Journal:  Lancet Infect Dis       Date:  2006-01       Impact factor: 25.071

3.  Rosiglitazone and implications for pharmacovigilance.

Authors:  Dhruv Kazi
Journal:  BMJ       Date:  2007-06-16

4.  Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

Authors:  J Gardon; N Gardon-Wendel; J Kamgno; J P Chippaux; M Boussinesq
Journal:  Lancet       Date:  1997-07-05       Impact factor: 79.321

5.  Patents and access to drugs in developing countries: an ethical analysis.

Authors:  Sigrid Sterckx
Journal:  Dev World Bioeth       Date:  2004-05       Impact factor: 2.294

Review 6.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

Authors:  M D Rawlins
Journal:  J R Coll Physicians Lond       Date:  1995 Jan-Feb
  7 in total
  31 in total

1.  The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.

Authors:  Hale Zerrin Toklu; Meral Keyer Uysal
Journal:  Pharm World Sci       Date:  2008-03-19

2.  Product safety spillovers and market viability for biologic drugs.

Authors:  John Romley; Tiffany Shih
Journal:  Int J Health Econ Manag       Date:  2016-12-23

3.  Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.

Authors:  Lise Aagaard; Johanna Strandell; Lars Melskens; Paw S G Petersen; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

4.  Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.

Authors:  Lassane Kabore; Pascal Millet; Souleymane Fofana; Driss Berdai; Caroline Adam; Françoise Haramburu
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

Review 5.  Specific features of medicines safety and pharmacovigilance in Africa.

Authors:  Ambrose O Isah; Shanthi N Pal; Sten Olsson; Alexander Dodoo; Rachida Soulayami Bencheikh
Journal:  Ther Adv Drug Saf       Date:  2012-02

6.  Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation.

Authors:  Oscar O Agoro; Sarah W Kibira; Jenny V Freeman; Hamish S F Fraser
Journal:  J Am Med Inform Assoc       Date:  2018-06-01       Impact factor: 4.497

7.  Pharmacovigilance in developing countries (part II): a path forward.

Authors:  Shaimaa Elshafie; Anne Marie Roberti; Iman Zaghloul
Journal:  Int J Clin Pharm       Date:  2018-08

8.  Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study.

Authors:  Peter Usman Bassi; Adeline I Osakwe; Ambrose Isah; Comfort Suku; Musa Kalat; Iliya Jalo; Robinson Daniel Wammanda; Chika Ugochukwu; Olubukula Adesina; Eno Etim Nyong; Frank Osungwu; Shanti Pal; Sylvester Chigozie Nwoasu; Magnus Wallberg; David Coulter
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

9.  Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.

Authors:  Thamir M Alshammari; Khaled K Alamri; Yazeed A Ghawa; Noura F Alohali; Shaza A Abualkol; Hisham S Aljadhey
Journal:  Int J Clin Pharm       Date:  2015-07-28

Review 10.  Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.

Authors:  Jackie Inch; Margaret C Watson; Stella Anakwe-Umeh
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.